Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Gastrointestinal 1

Conditions

Pancreatic Neoplasms 2Ovarian Neoplasms 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Thymus Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Pancreatitis 1Pancreatic Diseases 1Neoplasms 1Mesothelioma 1Melanoma 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1Adenoma, Islet Cell 1Adenocarcinoma 1

Interventions

Bevacizumab 41Paclitaxel 35Carboplatin 29pembrolizumab 22Specimen Handling 14Cisplatin 14Cyclophosphamide 13olaparib 12Blood Specimen Collection 11niraparib 10fludarabine 9Magnetic Resonance Spectroscopy 9Drug Therapy 9liposomal doxorubicin 8Topotecan 8Taxes 8Gemcitabine 8Fulvestrant 8Biopsy 8Doxorubicin 6cemiplimab 5abemaciclib 5Surveys and Questionnaires 5Standard of Care 5Injections 5Fluorouracil 5Cytoreduction Surgical Procedures 5trastuzumab deruxtecan 4mirvetuximab soravtansine 4aldesleukin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Ovarian Neoplasms × Histocompatibility Testing × Clear all
NCT06084195 2025-02-12

MR-O-MICS

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Recruiting
120 enrolled
Gynecologic

Ovarian Neoplasms

NCT06144762 2025-02-12

PANC-O-MICS

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Recruiting
150 enrolled
GastrointestinalGynecologic

Ovarian Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡